迈克maccura品牌怎么样 申请店铺

我要投票 迈克maccura在医疗器械行业中的票数:903 更新时间:2026-01-24
迈克maccura是哪个国家的品牌?「迈克maccura」是 迈克生物股份有限公司 旗下著名品牌。该品牌发源于四川省成都市,由创始人唐 *在1994年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力迈克maccura品牌出海!将品牌入驻外推网,定制迈克maccura品牌推广信息,可以显著提高迈克maccura产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

迈克maccura怎么样

迈克生物股份有限公司是中国具规模的临床体外诊断产品研发、生产企业之一。始创于1994年的迈克生物股份有限公司一直以来专注于体外诊断产品的研究、生产、销售和服务。

公司是经国家相关部门认证的“高新技术企业”,先后通过了CMD ISO13485、CQC ISO14001、TUV ISO13485 认证和部分产品CE认证。公司拥有研发、生产和管理运营团队;已完成从生物原材料、医学实验室产品到专业化服务的全产业链发展布局;具备研发制造体外诊断设备、试剂、校准品和质控品的系统化专业能力;产品涵盖生化、免疫、检测、血液、分子诊断、病理等技术平台。

公司是国际临床化学与检验医学联合会(IFCC)企业会员,是获得CNAS医学参考实验室认可的企业,是进入国际溯源联合委员会(JCTLM)医学参考测量实验室列表的企业,是欧盟标准物质委员会(IRMM)合作成员,承担国际参考物质赋值工作。

公司与国内、外的研究开发机构紧密结合,通过引进研发、生产及检测设备,逐渐形成了有特色的创新体系;与社会相关优势单位、实验室及个人合作,构建面向21世纪检验医学的创新型开放实验室。公司拥有丰富的市场管理经验和渠道管理能力,为产品经销商及终端客户提供完善的专业化服务。

公司以“科技服务人类健康”为使命,坚持量值溯源能力及医学实验室建设能力的提升,把为客户提供优质的产品作为企业的尊严和责任,将人类生命健康事业作为企业不断前进的动力和方向。


Mike biology Co., Ltd. is one of the large-scale clinical in vitro diagnostic product R & D and production enterprises in China. Founded in 1994, Mike biology Co., Ltd. has been focusing on the research, production, sales and service of in vitro diagnostic products. The company is a "high-tech enterprise" certified by relevant national departments, and has successively passed the certification of cmdiso13485, cqcsiiso14001, tuviso13485 and CE certification of some products. The company has a R & D, production and management operation team; has completed the whole industrial chain development layout from biological raw materials, medical laboratory products to professional services; has a systematic professional ability to develop and manufacture in vitro diagnostic equipment, reagents, calibrators and quality control products; products cover biochemical, immune, detection, blood, molecular diagnosis, pathology and other technical platforms. The company is an enterprise member of the International Federation of clinical chemistry and laboratory medicine (IFCC), an enterprise recognized by CNAs medical reference laboratory, an enterprise entering the list of medical reference measurement laboratories of JCTLM, and a cooperative member of IRMM, undertaking the assignment of international reference materials. The company is closely connected with research and development institutions at home and abroad. Through the introduction of R & D, production and testing equipment, the company has gradually formed a distinctive innovation system. It cooperates with relevant social advantageous units, laboratories and individuals to build an innovative and open laboratory for laboratory medicine in the 21st century. The company has rich experience in market management and channel management capabilities, and provides perfect professional services for product distributors and end customers. The company takes "science and technology serve human health" as its mission, adheres to the improvement of the capacity of traceability and medical laboratory construction, takes providing customers with high-quality products as the dignity and responsibility of the enterprise, and takes human life and health as the driving force and direction of the enterprise's continuous progress.

本文链接: https://brand.waitui.com/43e42d2a8.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

2小时前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

2小时前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

2小时前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

2小时前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

2小时前

本页详细列出关于迈克maccura的品牌信息,含品牌所属公司介绍,迈克maccura所处行业的品牌地位及优势。
咨询